Inulin-type β2-1 fructans have some effect on the antibody response to seasonal influenza vaccination in healthy middle-aged humans

Frontiers in Immunology

Volumn 6, Issue SEP, 2015, Pages

  Lomax, Amy R ^a   Cheung, Lydia V Y ^a   Noakes, Paul S ^a   Miles, Elizabeth A ^a   Calder, Philip C ^a,b,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Antibodies; Immune response; Oligofructose; Prebiotic; Vaccination

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; INSULIN TYPE BETA 2-1 FRUCTAN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MALTODEXTRIN; PREBIOTIC AGENT; T LYMPHOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA VACCINATION; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; SEASONAL INFLUENZA; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 84946561322     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00490     Document Type: Article

References (36)

1. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr (2010) 104(Suppl 2):S1-63. doi: 10.1017/S0007114510003363.
2. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol (2014) 11:506-14. doi:10.1038/nrgastro.2014.66.
3. Guigoz Y, Rochat F, Perruisseau-Carrier G, Rochat I, Schiffrin EJ. Effects of oligosaccharide on the faecal flora and non-specific immune system in elderly people. Nutr Res (2002) 22:13-25. doi:10.1016/S0271-5317(01)00354-2.
4. Fuller Z, Louis P, Mihajlovski A, Rungapamestry V, Ratcliffe B, Duncan AJ. Influence of cabbage processing methods and prebiotic manipulation of colonic microflora on glucosinolate breakdown in man. Br J Nutr (2007) 98:364-72. doi:10.1017/S0007114507709091.
5. Kolida S, Meyer D, Gibson GR. A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Eur J Clin Nutr (2007) 61:1189-95. doi:10.1038/sj.ejcn.1602636.
6. Ramnani P, Gaudier E, Bingham M, van Bruggen P, Tuohy KM, Gibson GR. Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: a human intervention study. Br J Nutr (2010) 104:233-40. doi:10.1017/S000711451000036X.
7. Kleessen B, Schwarz S, Boehm A, Fuhrmann H, Richter A, Henle T, et al. Jerusalem artichoke and chicory inulin in bakery products affect faecal microbiota of healthy volunteers. Br J Nutr (2007) 98:540-9. doi:10.1017/S0007114507730751.
8. Tuohy KM, Kolida S, Lustenberger AM, Gibson GR. The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides-a human volunteer study. Br J Nutr (2001) 86:341-8. doi:10.1079/BJN2001394.
9. Lomax AR, Cheung LV, Tuohy KM, Noakes PS, Miles EA, Calder PC. β2-1 fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: results from a randomised controlled trial. Br J Nutr (2012) 108:1818-28. doi:10.1017/S0007114511007276.
10. Lomax AR, Calder PC. Prebiotics, immune function, infection and inflammation: a review of the evidence. Br J Nutr (2009) 101:633-58. doi:10.1017/S0007114508055608.
11. Calder PC, Kew S. The immune system: a target for functional foods? Br J Nutr (2002) 88:S165-76. doi:10.1079/BJN2002682.
12. Cummings JH, Antoine J-M, Azpiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder PC, et al. PASSCLAIM-gut health and immunity. Eur J Clin Nutr (2004) 43(Suppl 2):II118-73. doi:10.1007/s00394-004-1205-4.
13. Albers R, Antoine JM, Bourdet-Sicard R, Calder PC, Gleeson M, Lesourd B, et al. Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr (2005) 94:452-81. doi:10.1079/BJN20051469.
14. Albers R, Bourdet-Sicard R, Braun D, Calder PC, Herz U, Lambert C, et al. Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health. Br J Nutr (2013) 110(Suppl 2):S1-30. doi:10.1017/S0007114513001505.
15. Calder PC. Biomarkers of immunity and inflammation for use in nutrition interventions: International Life Sciences Institute European branch work on selection criteria and interpretation. Endocr Metab Immune Disord Drug Targets (2014) 14:236-44. doi:10.2174/1871530314666140709091650.
16. Firmansyah A, Pramita G, Carrie-Fassler A, Haschke F, Link-Amster H. Improved humoral immune response to measles vaccine in infants receiving infant cereal with fructooligosaccharides. J Pediatr Gastroenterol Nutr (2001) 31:A521.
17. Bunout D, Hirsch S, Pia de la Maza M, Munoz C, Haschke F, Steenhout P, et al. Effects of prebiotics on the immune response to vaccination in the elderly. JPEN J Parenter Enteral Nutr (2002) 26:372-6. doi:10.1177/0148607102026006372.
18. Duggan C, Penny ME, Hibberd P, Gil A, Huapaya A, Cooper A, et al. Oligofructose-supplemented infant cereal: 2 randomized, blinded, community-based trials in Peruvian infants. Am J Clin Nutr (2003) 77:937-42.
19. Langkamp-Henken B, Bender BS, Gardner EM, Herrlinger-Garcia KA, Kelley MJ, Murasko DM, et al. Nutritional formula enhanced immune function and reduced days of symptoms of upper respiratory tract infection in seniors. J Am Geriatr Soc (2004) 52:3-12. doi:10.1111/j.1532-5415.2004.52003.x.
20. Langkamp-Henken B, Wood SM, Herrlinger-Garcia KA, Thomas DJ, Stechmiller JK, Bender BS, et al. Nutritional formula improved immune profiles of seniors living in nursing homes. J Am Geriatr Soc (2006) 54:1861-70. doi:10.1111/j.1532-5415.2006.00982.x.
21. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child (2006) 91:814-9. doi:10.1136/adc.2006.098251.
22. Bunout D, Barrera G, Hirsch S, Gattas V, Pia De la Maza M, Haschke F, et al. Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. JPEN J Parenter Enteral Nutr (2004) 28:348-54. doi:10.1177/0148607104028005348.
23. Pérez N, Iannicelli JC, Girard-Bosch C, González S, Varea A, Disalvo L, et al. Effect of probiotic supplementation on immunoglobulins, isoagglutinins and antibody response in children of low socio-economic status. Eur J Nutr (2010) 49:173-9. doi:10.1007/s00394-009-0063-5.
24. van den Berg JP1, Westerbeek EA, van der Klis FR, Berbers GA, Lafeber HN, van Elburg RM. Neutral and acidic oligosaccharides supplementation does not increase the vaccine antibody response in preterm infants in a randomized clinical trial. PLoS One (2013) 8:e70904. doi:10.1371/journal.pone.0070904.
25. Salvini F, Riva E, Salvatici E, Boehm G, Jelinek J, Banderali G, et al. A specific prebiotic mixture added to starting infant formula has long-lasting bifidogenic effects. J Nutr (2011) 141:1335-9. doi:10.3945/jn.110.136747.
26. Stam J, van Stuijvenberg M, Garssen J, Knipping K, Sauer PJ. A mixture of three prebiotics does not affect vaccine specific antibody responses in healthy term infants in the first year of life. Vaccine (2011) 29:7766-72. doi:10.1016/j.vaccine.2011.07.110.
27. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/en/.
28. Available from: http://ecdc.europa.eu/en/healthtopics/seasonal_influenza/vaccines/Pages/influenza_vaccination.aspx.
29. Olivares M, Diaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonolla J, Navas M, et al. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition (2007) 23:254-60. doi:10.1016/j.nut.2007.01.004.
30. Schapiro JM, Segev Y, Rannon L, Alkan M, Rager-Zisman B. Natural killer (NK) cell response after vaccination of volunteers with killed influenza vaccine. J Med Virol (1990) 30:196-200. doi:10.1002/jmv.1890300310.
31. Huang YP, Pechere JC, Michel M, Gauthey L, Loreto M, Curran JA, et al. In vivo T cell activation, in vitro defective IL-2 secretion, and response to influenza vaccination in elderly women. J Immunol (1992) 148:715-22.
32. Boge T, Rémigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine (2009) 27:5677-84.
33. Davidson LE, Fiorino AM, Snydman DR, Hibberd PL. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr (2011) 65:501-7. doi:10.1038/ejcn.2010.289.
34. Degelau J, Guay D, Hallgren H. The effect of DHEAS on influenza vaccination in aging adults. J Am Geriatr Soc (1997) 45:747-51. doi:10.1111/j.1532-5415.1997.tb01482.x.
35. Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, et al. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol (2004) 113:717-24. doi:10.1016/j.jaci.2003.12.584.
36. Cox RJ, Mykkeltvedt E, Sjursen H, Haaheim LR. The effect of zanamivir treatment on the early immune response to influenza vaccination. Vaccine (2001) 19:4743-9. doi:10.1016/S0264-410X(01)00219-5.